SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000929638-18-000965
Filing Date
2018-12-07
Accepted
2018-12-07 17:22:19
Documents
2
Group Members
ABRAMS CAPITAL MANAGEMENT, LLCABRAMS CAPITAL PARTNERS II L.P.ABRAMS CAPITAL, LLCDAVID ABRAMS

Document Format Files

Seq Description Document Type Size
1 abrams13g.htm SC 13G 101758
2 JOINT FILING AGREEMENT exhibit99-1.htm EX-99.1 16933
  Complete submission text file 0000929638-18-000965.txt   120403
Mailing Address 222 BERKELEY STREET, 21ST FLOOR BOSTON MA 02116
Business Address 222 BERKELEY STREET, 21ST FLOOR BOSTON MA 02116 617-646-6100
ABRAMS CAPITAL MANAGEMENT, L.P. (Filed by) CIK: 0001358706 (see all company filings)

IRS No.: 204043368 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Subject) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88058 | Film No.: 181224314
SIC: 2834 Pharmaceutical Preparations